Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (321-330 of 434) with videos related to

Pageof 44
Sort By:
Rheumatology (Oxford, England)|November 28, 2022
Ocular manifestations of ANCA-associated vasculitisMats L Junek, Lily Zhao, Stephanie Garner, et al.
The Journal of Rheumatology|June 7, 2007
The future of damage assessment in vasculitisPhilip Seo, Raashid A Luqmani, Oliver Flossmann, et al.
Clinical Immunology (Orlando, Fla.)|August 25, 2023
Mitochondrial-mediated inflammation and platelet activation in giant cell arteritisDespina Michailidou, Peter C Grayson, Payton Hermanson, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 23, 2018
Serum S100 Proteins as a Marker of Disease Activity in Large Vessel VasculitisJason Michael Springer, Paul Monach, David Cuthbertson, et al.
Nature Reviews. Rheumatology|October 16, 2025
Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitisMarta Casal Moura, Peter A Merkel, David Jayne, et al.
Arthritis Care & Research|October 4, 2016
Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated VasculitisZachary S Wallace, Eli M Miloslavsky, Matthew Cascino, et al.
Plos One|October 12, 2018
Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitisRennie L Rhee, Cecile T J Holweg, Kit Wong, et al.
Clinical and Experimental Rheumatology|March 11, 2017
IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Esha Oommen, Amber Hummel, Lisa Allmannsberger, et al.
Journal of Scleroderma and Related Disorders|July 28, 2021
Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomesAlain Lescoat, Susan L Murphy, David Roofeh, et al.
The Journal of Rheumatology|September 3, 2019
Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of VasculitisAlicia Rodriguez-Pla, Roscoe L Warner, David Cuthbertson, et al.
Pageof 44

Showing results (321-330 of 434) with videos related to

Sort By:
Pageof 44
Rheumatology (Oxford, England)|November 28, 2022
Ocular manifestations of ANCA-associated vasculitisMats L Junek, Lily Zhao, Stephanie Garner, et al.
The Journal of Rheumatology|June 7, 2007
The future of damage assessment in vasculitisPhilip Seo, Raashid A Luqmani, Oliver Flossmann, et al.
Clinical Immunology (Orlando, Fla.)|August 25, 2023
Mitochondrial-mediated inflammation and platelet activation in giant cell arteritisDespina Michailidou, Peter C Grayson, Payton Hermanson, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 23, 2018
Serum S100 Proteins as a Marker of Disease Activity in Large Vessel VasculitisJason Michael Springer, Paul Monach, David Cuthbertson, et al.
Nature Reviews. Rheumatology|October 16, 2025
Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitisMarta Casal Moura, Peter A Merkel, David Jayne, et al.
Arthritis Care & Research|October 4, 2016
Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated VasculitisZachary S Wallace, Eli M Miloslavsky, Matthew Cascino, et al.
Plos One|October 12, 2018
Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitisRennie L Rhee, Cecile T J Holweg, Kit Wong, et al.
Clinical and Experimental Rheumatology|March 11, 2017
IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Esha Oommen, Amber Hummel, Lisa Allmannsberger, et al.
Journal of Scleroderma and Related Disorders|July 28, 2021
Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomesAlain Lescoat, Susan L Murphy, David Roofeh, et al.
The Journal of Rheumatology|September 3, 2019
Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of VasculitisAlicia Rodriguez-Pla, Roscoe L Warner, David Cuthbertson, et al.
Pageof 44